Robert W. Baird Cuts Humana (NYSE:HUM) Price Target to $264.00

Humana (NYSE:HUM) had its target price reduced by Robert W. Baird from $280.00 to $264.00 in a report published on Thursday morning,MarketScreener reports. They currently have a neutral rating on the insurance provider’s stock.

Several other research analysts have also weighed in on the stock. Bank of America upped their target price on shares of Humana from $280.00 to $300.00 and gave the stock a “neutral” rating in a research report on Friday, October 10th. Guggenheim reaffirmed a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Truist Financial reduced their price objective on Humana from $300.00 to $285.00 and set a “hold” rating for the company in a report on Monday, November 10th. Royal Bank Of Canada upped their target price on Humana from $283.00 to $322.00 and gave the company an “outperform” rating in a report on Thursday, August 21st. Finally, Jefferies Financial Group raised Humana from a “hold” rating to a “buy” rating and lifted their price target for the stock from $253.00 to $313.00 in a research note on Friday, December 5th. Nine research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $295.11.

Humana Trading Up 0.7%

NYSE:HUM opened at $268.44 on Thursday. Humana has a 1 year low of $206.87 and a 1 year high of $315.35. The company has a debt-to-equity ratio of 0.68, a quick ratio of 2.02 and a current ratio of 2.02. The stock has a fifty day moving average price of $262.41 and a two-hundred day moving average price of $258.29. The stock has a market capitalization of $32.29 billion, a price-to-earnings ratio of 25.16, a PEG ratio of 1.57 and a beta of 0.46.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, November 5th. The insurance provider reported $3.24 EPS for the quarter, topping the consensus estimate of $2.95 by $0.29. The company had revenue of $32.65 billion for the quarter, compared to analyst estimates of $31.99 billion. Humana had a net margin of 1.02% and a return on equity of 12.86%. The business’s revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the firm earned $4.16 EPS. As a group, sell-side analysts anticipate that Humana will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be paid a $0.885 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $3.54 annualized dividend and a yield of 1.3%. Humana’s payout ratio is presently 33.18%.

Institutional Investors Weigh In On Humana

Several hedge funds have recently modified their holdings of HUM. Unison Advisors LLC lifted its stake in shares of Humana by 0.4% during the third quarter. Unison Advisors LLC now owns 10,137 shares of the insurance provider’s stock valued at $2,646,000 after buying an additional 37 shares during the period. Insigneo Advisory Services LLC lifted its stake in shares of Humana by 3.0% during the 3rd quarter. Insigneo Advisory Services LLC now owns 1,484 shares of the insurance provider’s stock worth $386,000 after purchasing an additional 43 shares during the period. Synovus Financial Corp boosted its holdings in shares of Humana by 2.0% during the third quarter. Synovus Financial Corp now owns 2,278 shares of the insurance provider’s stock worth $593,000 after purchasing an additional 45 shares during the last quarter. Blue Trust Inc. grew its position in shares of Humana by 3.6% in the second quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider’s stock valued at $334,000 after purchasing an additional 48 shares during the period. Finally, Private Wealth Management Group LLC increased its stake in Humana by 47.5% in the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock valued at $39,000 after purchasing an additional 48 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.